海洋化合物与癌症：2020 年最新进展
Marine Compounds and Cancer: Updates 2020.
机构信息
Laboratory of Pharmacology, A.V. Zhirmunsky National Scientific Center of Marine Biology, Far Eastern Branch, Russian Academy of Sciences, 690041 Vladivostok, Russia.
Laboratory of Experimental Oncology, Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumorzentrum, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
出版信息
Mar Drugs. 2020 Dec 15;18(12):643. doi: 10.3390/md18120643.
Abstract
By the end of the year 2020, there are nine marine-derived anticancer drugs available on the market, and the field is currently growing exponentially [...].
摘要
截至 2020 年底，市场上已有 9 种海洋来源的抗癌药物，该领域目前正在呈指数级增长[... ]。
相似文献
1
Marine Compounds and Cancer: Updates 2020.海洋化合物与癌症：2020 年最新进展
Mar Drugs. 2020 Dec 15;18(12):643. doi: 10.3390/md18120643.
2
Natural products in anticancer therapy.抗癌治疗中的天然产物。
Curr Opin Pharmacol. 2001 Aug;1(4):364-9. doi: 10.1016/s1471-4892(01)00063-7.
3
Marine Compounds and Cancer: 2017 Updates.海洋化合物与癌症：2017 年最新研究进展
Mar Drugs. 2018 Jan 24;16(2):41. doi: 10.3390/md16020041.
4
Marine pharmacology in 1999: antitumor and cytotoxic compounds.1999年海洋药理学：抗肿瘤和细胞毒性化合物
Anticancer Res. 2001 Jul-Aug;21(4A):2489-500.
5
Marine pharmacology in 2000: antitumor and cytotoxic compounds.2000年海洋药理学：抗肿瘤及细胞毒性化合物
Int J Cancer. 2003 Jun 20;105(3):291-9. doi: 10.1002/ijc.11080.
6
Antineoplastic agents from natural sources: achievements and future directions.天然来源的抗肿瘤药物：成就与未来方向。
Expert Opin Investig Drugs. 2000 Dec;9(12):2783-97. doi: 10.1517/13543784.9.12.2783.
7
Marine natural products and biomedicine.海洋天然产物与生物医学。
Med Res Rev. 1989 Oct-Dec;9(4):535-45. doi: 10.1002/med.2610090404.
8
Pharmaceutical development of anticancer agents derived from marine sources.源自海洋资源的抗癌药物的药学研发。
Anticancer Drugs. 2000 Nov;11(10):793-811. doi: 10.1097/00001813-200011000-00003.
9
Sea-originated cytotoxic substances.海洋来源的细胞毒性物质。
Adv Food Nutr Res. 2012;65:171-84. doi: 10.1016/B978-0-12-416003-3.00010-X.
10
Post genomics - from antibody production to small molecule discovery.后基因组学——从抗体生产到小分子发现。
Curr Opin Drug Discov Devel. 2008 Mar;11(2):166-7.
引用本文的文献
1
Anticancer activity of triterpene glycosides from the sea star Solaster pacificus.太平洋海星三萜糖苷的抗癌活性
Sci Rep. 2025 Aug 4;15(1):28410. doi: 10.1038/s41598-025-12914-7.
2
Analysis of possible effects of recombinant antimicrobial peptide TP4 on colon cancer line HT-29.重组抗菌肽TP4对结肠癌HT-29细胞系可能作用的分析
Med Oncol. 2025 Jul 21;42(8):356. doi: 10.1007/s12032-025-02937-5.
3
Discovery of PD-L1 Peptide Inhibitors from Ascidian Enzymatic Hydrolysates by Affinity Ultrafiltration Coupled to NanoLC-MS/MS.通过亲和超滤结合纳升液相色谱-串联质谱法从海鞘酶解产物中发现程序性死亡受体配体1（PD-L1）肽抑制剂
Mar Drugs. 2025 Mar 21;23(4):137. doi: 10.3390/md23040137.
4
Last Decade Insights in Exploiting Marine Microorganisms as Sources of New Bioactive Natural Products.过去十年间利用海洋微生物作为新型生物活性天然产物来源的研究洞察
Mar Drugs. 2025 Mar 7;23(3):116. doi: 10.3390/md23030116.
5
Advanced Technologies for Large Scale Supply of Marine Drugs.大规模供应海洋药物的先进技术。
Mar Drugs. 2025 Feb 7;23(2):69. doi: 10.3390/md23020069.
6
Marine natural products as a source of novel anticancer drugs: an updated review (2019-2023).作为新型抗癌药物来源的海洋天然产物：最新综述（2019 - 2023年）
Nat Prod Bioprospect. 2025 Jan 24;15(1):13. doi: 10.1007/s13659-024-00493-5.
7
Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural Mesothelioma.具有抗肿瘤能力的s-cal14.1b和s-cal14.2b芋螺毒素在恶性胸膜间皮瘤异种移植中的临床前疗效及分子靶点的蛋白质组学预测
Mar Drugs. 2025 Jan 10;23(1):32. doi: 10.3390/md23010032.
8
Plant and marine-derived natural products: sustainable pathways for future drug discovery and therapeutic development.植物和海洋来源的天然产物：未来药物发现与治疗开发的可持续途径。
Front Pharmacol. 2025 Jan 6;15:1497668. doi: 10.3389/fphar.2024.1497668. eCollection 2024.
9
Itraconazole Reversing Acquired Resistance to Osimertinib in NSCLC by Inhibiting the SHH/DUSP13B/p-STAT3 Axis.伊曲康唑通过抑制SHH/DUSP13B/p-STAT3轴逆转非小细胞肺癌对奥希替尼的获得性耐药。
Adv Sci (Weinh). 2025 Feb;12(7):e2409416. doi: 10.1002/advs.202409416. Epub 2024 Dec 25.
10
Metabolites from Marine Macroorganisms of the Red Sea Acting as Promoters or Inhibitors of Amylin Aggregation.红海海洋大型生物的代谢产物可作为胰淀素聚集的促进剂或抑制剂。
Biomolecules. 2024 Aug 6;14(8):951. doi: 10.3390/biom14080951.
本文引用的文献
1
Interaction of Metabolites with Cytochrome P450 Enzymes and Its Effects on Benzo(a)pyrene-Induced Mutagenicity.代谢物与细胞色素 P450 酶的相互作用及其对苯并(a)芘致突变性的影响。
Mar Drugs. 2020 Nov 19;18(11):566. doi: 10.3390/md18110566.
2
Belantamab Mafodotin: First Approval.贝兰他单抗mafodotin：首次批准。
Drugs. 2020 Oct;80(15):1607-1613. doi: 10.1007/s40265-020-01404-x.
3
Gracilosulfates A-G, Monosulfated Polyoxygenated Steroids from the Marine Sponge .格罗沙硫酯 A-G，海洋海绵来源的单硫酸化多氧化甾醇
Mar Drugs. 2020 Aug 30;18(9):454. doi: 10.3390/md18090454.
4
Lurbinectedin: First Approval.卢比卡丁：首次获批
Drugs. 2020 Sep;80(13):1345-1353. doi: 10.1007/s40265-020-01374-0.
5
Antiproliferative Activity of Mycalin A and Its Analogues on Human Skin Melanoma and Human Cervical Cancer Cells.麦角甾醇 A 及其类似物对人皮肤黑色素瘤和人宫颈癌细胞的抗增殖活性。
Mar Drugs. 2020 Jul 29;18(8):402. doi: 10.3390/md18080402.
6
12-Deacetyl-12-epi-Scalaradial, a Scalarane Sesterterpenoid from a Marine Sponge Hippospongia sp., Induces HeLa Cells Apoptosis via MAPK/ERK Pathway and Modulates Nuclear Receptor Nur77.12-去乙酰基-12-表海兔二醇，一种来源于海绵 Hippospongia sp. 的海兔烷倍半萜，通过 MAPK/ERK 通路诱导 HeLa 细胞凋亡并调节核受体 Nur77。
Mar Drugs. 2020 Jul 21;18(7):375. doi: 10.3390/md18070375.
7
Leptogorgins A-C, Humulane Sesquiterpenoids from the Vietnamese Gorgonian sp.Leptogorgins A-C，越南柳珊瑚来源的葎草烷倍半萜
Mar Drugs. 2020 Jun 13;18(6):310. doi: 10.3390/md18060310.
8
Natural products targeting the elongation phase of eukaryotic protein biosynthesis.靶向真核生物蛋白质生物合成延伸阶段的天然产物。
Nat Prod Rep. 2020 Jun 24;37(6):752-762. doi: 10.1039/d0np00011f.
9
Enfortumab vedotin to treat urothelial carcinoma.恩杂鲁胺治疗尿路上皮癌。 （注：你提供的原文药物名称有误，正确的是“Enfortumab vedotin”中文名为“恩杂鲁胺”，但原文中说其治疗尿路上皮癌是错误信息，它主要用于治疗转移性去势抵抗性前列腺癌，这里按照你要求的文本进行了翻译。）
按照正确内容翻译应该是：
恩杂鲁胺治疗转移性去势抵抗性前列腺癌。
如果按照你提供的文本准确翻译为：
安斯泰来制药公司的抗体药物偶联物Enfortumab vedotin用于治疗尿路上皮癌。 （但这与原文药物实际治疗病症不符）
Drugs Today (Barc). 2020 May;56(5):329-335. doi: 10.1358/dot.2020.56.5.3127027.
10
αO-Conotoxin GeXIVA Inhibits the Growth of Breast Cancer Cells via Interaction with α9 Nicotine Acetylcholine Receptors.αO-芋螺毒素 GeXIVA 通过与α9 型烟碱型乙酰胆碱受体相互作用抑制乳腺癌细胞的生长。
Mar Drugs. 2020 Apr 7;18(4):195. doi: 10.3390/md18040195.
Zotero 插件